Growth Metrics

GT Biopharma (GTBP) Leases (2019 - 2020)

GT Biopharma (GTBP) has disclosed Leases for 2 consecutive years, with $72000.0 as the latest value for Q3 2020.

  • On a quarterly basis, Leases fell 45.86% to $72000.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $72000.0, a 45.86% decrease, with the full-year FY2019 number at $110000.0, changed N/A from a year prior.
  • Leases was $72000.0 for Q3 2020 at GT Biopharma, down from $80000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $153000.0 in Q1 2019 to a low of $72000.0 in Q3 2020.